Taketoshi Furugohri

DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles

Taketoshi Furugohri, K. Isobe, Yuko Honda et al. · Journal of Thrombosis and Haemostasis · 2008 · 298 citations · Full text

Vivo Pharmacological Profiles, Medicine, Mechanism Of Action +5

Different antithrombotic properties of factor Xa inhibitor and thrombin inhibitor in rat thrombosis models

Taketoshi Furugohri, Yoko Shiozaki, Sumie Muramatsu et al. · European Journal of Pharmacology · 2005 · 40 citations

Thrombopoiesis, Thrombosis, Blood Platelet +12

The effects of warfarin and edoxaban, an oral direct factor Xa inhibitor, on gammacarboxylated (Gla-osteocalcin) and undercarboxylated osteocalcin (uc-osteocalcin) in rats

Y Morishima, Chikako Kamisato, Yuko Honda et al. · Thrombosis Research · 2012 · 34 citations

Inflammation, Anti-inflammatory, Medicine +5

Cycloalkanediamine derivatives as novel blood coagulation factor Xa inhibitors

Tsutomu Nagata, Toshiharu Yoshino, Noriyasu Haginoya et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 33 citations · Full text

Medicinal Chemistry, Medicine, Cycloalkanediamine Derivatives +6

Impact of antithrombin deficiency on efficacy of edoxaban and antithrombin-dependent anticoagulants, fondaparinux, enoxaparin, and heparin

Toshio Fukuda, Chikako Kamisato, Yuko Honda et al. · Thrombosis Research · 2013 · 20 citations · Full text

Thrombosis, Venous Thrombosis, Cardiovascular Disease +12